Rare diseases
Investigational molecules
Locations
Back to Hungary68 clinical trials in Veszprem, Hungary across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.
Long-Term Safety and Efficacy of Zasocitinib in Adults with Active Psoriatic Arthritis
HungaryA study to evaluate the effectiveness and safety of duvakitug in patients with moderate to severe Crohn's disease
HungaryA study to evaluate the efficacy and safety of duvakitug in patients with moderate to severe Crohn's disease
HungaryLong-term safety study of deucravacitinib compared to ustekinumab in adults with moderate to severe plaque psoriasis
HungaryA study of duvakitug for patients with moderately to severely active ulcerative colitis to see if it works and is safe as maintenance therapy
HungaryA study testing duvakitug for patients with moderately to severely active ulcerative colitis
HungaryStudy of laroprovstat (AZD0780) to reduce heart attack, stroke and vascular complications in patients with atherosclerotic cardiovascular disease or high risk of developing it
HungaryStudy of tulisokibart compared to placebo in adults with moderate to severe Crohn's disease
HungaryStudy of Zasocitinib and Apremilast for Adults with Active Psoriatic Arthritis Who Have Not Used Biologic Medicines
HungaryStudy on the Effectiveness and Safety of JNJ-77242113 for Patients with Active Psoriatic Arthritis Who Have Previously Used Biologic Treatments
HungaryStudy on the Effectiveness of Abelacimab for High-Risk Atrial Fibrillation Patients Unsuitable for Oral Anticoagulation
HungaryNipocalimab in Adults with Moderate to Severe Systemic Lupus Erythematosus
HungaryThe busiest research cities in the country
What the registry says about research in the country
Comprehensive studies evaluating novel treatments for moderate to severe plaque psoriasis, including investigations of innovative therapies like JNJ-77242113 and ESK-001.
Multiple trials focusing on efficacy assessment and treatment response durability.
Extensive research into psoriatic arthritis treatments, including trials with zasocitinib, sonelokimab, and deucravacitinib for both biologic-naïve and experienced patients.
Focus on reducing symptoms and improving quality of life for patients.
Innovative research targeting systemic lupus erythematosus and other inflammatory conditions, with studies on medications like GLPG3667 and upadacitinib.
Comprehensive evaluation of disease activity and treatment responses.
Studies examining treatments for knee osteoarthritis, including comparative analysis of different chondroitin sulfate formulations and novel compounds.
Focus on both symptom management and functional outcomes.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
